ampelopsin has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; Hong, Z; Huang, Y; Liang, Z; Tang, M; Wang, Y; Yang, K; Zeng, C | 1 |
| Bai, XJ; Gao, W; Li, ZF; Liu, QX; Liu, T; Liu, XH; Wang, YC; Xu, XE; Zheng, Q | 1 |
2 other study(ies) available for ampelopsin and Lung Injury, Acute
| Article | Year |
|---|---|
Ampelopsin attenuates Staphylococcus aureus Alpha-Toxin-Induced Lung Injury.
Topics: Acute Lung Injury; Animals; Flavonoids; Hemolysin Proteins; Humans; Mice; Staphylococcus aureus | 2023 |
Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonols; Inflammasomes; Male; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Sepsis | 2019 |